142 related articles for article (PubMed ID: 17869320)
1. Identification of a 17-nucleotide splicing enhancer in HPV-16 L1 that counteracts the effect of multiple hnRNP A1-binding splicing silencers.
Zhao X; Fay J; Lambkin H; Schwartz S
Virology; 2007 Dec; 369(2):351-63. PubMed ID: 17869320
[TBL] [Abstract][Full Text] [Related]
2. Identification of an hnRNP A1-dependent splicing silencer in the human papillomavirus type 16 L1 coding region that prevents premature expression of the late L1 gene.
Zhao X; Rush M; Schwartz S
J Virol; 2004 Oct; 78(20):10888-905. PubMed ID: 15452209
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneous Nuclear Ribonucleoprotein A1 (hnRNP A1) and hnRNP A2 Inhibit Splicing to Human Papillomavirus 16 Splice Site SA409 through a UAG-Containing Sequence in the E7 Coding Region.
Zheng Y; Jönsson J; Hao C; Shoja Chaghervand S; Cui X; Kajitani N; Gong L; Wu C; Schwartz S
J Virol; 2020 Sep; 94(20):. PubMed ID: 32759322
[TBL] [Abstract][Full Text] [Related]
4. Suppression of HPV-16 late L1 5'-splice site SD3632 by binding of hnRNP D proteins and hnRNP A2/B1 to upstream AUAGUA RNA motifs.
Li X; Johansson C; Glahder J; Mossberg AK; Schwartz S
Nucleic Acids Res; 2013 Dec; 41(22):10488-508. PubMed ID: 24013563
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of HPV-16 L1 expression from L1 cDNAs correlates with the presence of hnRNP A1 binding sites in the L1 coding region.
Zhao X; Schwartz S
Virus Genes; 2008 Feb; 36(1):45-53. PubMed ID: 18040766
[TBL] [Abstract][Full Text] [Related]
6. A downstream polyadenylation element in human papillomavirus type 16 L2 encodes multiple GGG motifs and interacts with hnRNP H.
Oberg D; Fay J; Lambkin H; Schwartz S
J Virol; 2005 Jul; 79(14):9254-69. PubMed ID: 15994820
[TBL] [Abstract][Full Text] [Related]
7. Specific interaction between hnRNP H and HPV16 L1 proteins: implications for late gene auto-regulation enabling rapid viral capsid protein production.
Zheng ZZ; Sun YY; Zhao M; Huang H; Zhang J; Xia NS; Miao J; Zhao Q
Biochem Biophys Res Commun; 2013 Jan; 430(3):1047-53. PubMed ID: 23261416
[TBL] [Abstract][Full Text] [Related]
8. A splicing enhancer in the E4 coding region of human papillomavirus type 16 is required for early mRNA splicing and polyadenylation as well as inhibition of premature late gene expression.
Rush M; Zhao X; Schwartz S
J Virol; 2005 Sep; 79(18):12002-15. PubMed ID: 16140776
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneous Nuclear Ribonucleoprotein C Proteins Interact with the Human Papillomavirus Type 16 (HPV16) Early 3'-Untranslated Region and Alleviate Suppression of HPV16 Late L1 mRNA Splicing.
Dhanjal S; Kajitani N; Glahder J; Mossberg AK; Johansson C; Schwartz S
J Biol Chem; 2015 May; 290(21):13354-71. PubMed ID: 25878250
[TBL] [Abstract][Full Text] [Related]
10. hnRNP A1 controls HIV-1 mRNA splicing through cooperative binding to intron and exon splicing silencers in the context of a conserved secondary structure.
Damgaard CK; Tange TO; Kjems J
RNA; 2002 Nov; 8(11):1401-15. PubMed ID: 12458794
[TBL] [Abstract][Full Text] [Related]
11. Serine/Arginine-Rich Splicing Factor 3 and Heterogeneous Nuclear Ribonucleoprotein A1 Regulate Alternative RNA Splicing and Gene Expression of Human Papillomavirus 18 through Two Functionally Distinguishable cis Elements.
Ajiro M; Tang S; Doorbar J; Zheng ZM
J Virol; 2016 Oct; 90(20):9138-52. PubMed ID: 27489271
[TBL] [Abstract][Full Text] [Related]
12. The hnRNP A1 protein regulates HIV-1 tat splicing via a novel intron silencer element.
Tange TO; Damgaard CK; Guth S; Valcárcel J; Kjems J
EMBO J; 2001 Oct; 20(20):5748-58. PubMed ID: 11598017
[TBL] [Abstract][Full Text] [Related]
13. Eight nucleotide substitutions inhibit splicing to HPV-16 3'-splice site SA3358 and reduce the efficiency by which HPV-16 increases the life span of primary human keratinocytes.
Li X; Johansson C; Cardoso Palacios C; Mossberg A; Dhanjal S; Bergvall M; Schwartz S
PLoS One; 2013; 8(9):e72776. PubMed ID: 24039800
[TBL] [Abstract][Full Text] [Related]
14. HPV-16 RNA processing.
Schwartz S
Front Biosci; 2008 May; 13():5880-91. PubMed ID: 18508629
[TBL] [Abstract][Full Text] [Related]
15. Polypyrimidine tract binding protein induces human papillomavirus type 16 late gene expression by interfering with splicing inhibitory elements at the major late 5' splice site, SD3632.
Somberg M; Zhao X; Fröhlich M; Evander M; Schwartz S
J Virol; 2008 Apr; 82(7):3665-78. PubMed ID: 18216120
[TBL] [Abstract][Full Text] [Related]
16. Translational inhibition in vitro of human papillomavirus type 16 L2 mRNA mediated through interaction with heterogenous ribonucleoprotein K and poly(rC)-binding proteins 1 and 2.
Collier B; Goobar-Larsson L; Sokolowski M; Schwartz S
J Biol Chem; 1998 Aug; 273(35):22648-56. PubMed ID: 9712894
[TBL] [Abstract][Full Text] [Related]
17. The alternative splicing factor hnRNP A1 is up-regulated during virus-infected epithelial cell differentiation and binds the human papillomavirus type 16 late regulatory element.
Cheunim T; Zhang J; Milligan SG; McPhillips MG; Graham SV
Virus Res; 2008 Feb; 131(2):189-98. PubMed ID: 17950949
[TBL] [Abstract][Full Text] [Related]
18. Synergistic stimulation of HIV-1 rev-dependent export of unspliced mRNA to the cytoplasm by hnRNP A1.
Najera I; Krieg M; Karn J
J Mol Biol; 1999 Feb; 285(5):1951-64. PubMed ID: 9925777
[TBL] [Abstract][Full Text] [Related]
19. Multiple ASF/SF2 sites in the human papillomavirus type 16 (HPV-16) E4-coding region promote splicing to the most commonly used 3'-splice site on the HPV-16 genome.
Somberg M; Schwartz S
J Virol; 2010 Aug; 84(16):8219-30. PubMed ID: 20519389
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus type 16 variant analysis of E6, E7, and L1 genes and long control region in biopsy samples from cervical cancer patients in north India.
Pande S; Jain N; Prusty BK; Bhambhani S; Gupta S; Sharma R; Batra S; Das BC
J Clin Microbiol; 2008 Mar; 46(3):1060-6. PubMed ID: 18199779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
